Rethinking the Economics of Chromatography: New Technologies and Hidden Costs

Tim N. Warner;Sam Nuchumson;

Publication

Article

January 15, 2003

BioPharm International

BioPharm International-01-01-2003

Volume16

Issue 1

Rethinking the Economics of Chromatography: New Technologies and Hidden Costs

Author(s):

Tim N. Warner,Sam Nuchumson

by Tim N. Warner and Sam Nuchumson, Pall Life Sciences If the hidden expenses associated with laboratory purchases ? labor, cleaning, buffers, validation, time delays ? are identified, reduced processing costs, higher throughput, and accelerated time-to-market are possible. This comparison between resin and membrane chromatography helps shed light on some hidden costs.

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

Virus Inactivation in the 1990s and into the 21st Century: Part 4, Culture Media, Biotechnology Products, and Vaccines

Biotech World: Canada's Supreme Court says "No" to Harvard Mouse

Rethinking the Economics of Chromatography: New Technologies and Hidden Costs

Outsourcing Outlook: Using Virtual Private Networks to Gain Competitive Advantage

Inside Washington: Coverage and Consolidation ? Key Issues for Biotech Companies

Employing Near-Infrared Spectroscopic Methods of Analysis for Fermentation Monitoring and Control: Part 2, Implementation Strategies

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Rethinking the Economics of Chromatography: New Technologies and Hidden Costs

Newsletter